Calculate Hemato-Onco vs Multiple Myeloma [MM] Usage & Stats
Calculate Hemato-Onco app is a helpful tool in the daily practice of physicians in caring for patients with cancer.
1. The BSA & Dose Calculator (Haycock formula) allows you to quickly calculate or check the drug dose required for a patient.
2. DIPSS calculator for estimation of prognosis in myelofibrosis.
3. IPSS-R is a modified prognostic index for myelodysplastic syndromes.
Disclaimer
We make every effort to ensure that the information provided in the application is accurate, up-to-date and verified. At the same time, it should be remembered that the above-mentioned information is intended only as a guide for the provision of health services. The final therapeutic decision is made by the Healthcare Professional based on specific medical situation, scientific source materials as well as his/hers experience and knowledge.
Both application developers and consultants are not responsible for the consequences of application of the information contained in the application.
4Pharma is not responsible for correctness of the information provided on this application and shall bear no liability or otherwise be responsible for any damage caused from using any information provided on this application.
Please refer to your local Health Authorities for more information.
- Apple App Store
- Free
- Medical
Store Rank
- -
@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Multiple Myeloma @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Multiple Myeloma content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
- Apple App Store
- Free
- Medical
Store Rank
- -
Calculate Hemato-Onco VS. 
Multiple Myeloma [MM]December 30, 2024